Caenorhabditis elegans as a model for obesity research

International Journal of Obesity

Volumn 36, Issue 2, 2012, Pages 186-194

  Zheng, J ^a   Greenway, F L ^b  

^a LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

C. elegans; insulin; lipogenesis; oxidation; satiety; serotonin

Indexed keywords

CLOZAPINE; FLUPHENAZINE; OLANZAPINE; PEPTIDE TRANSPORTER 1; PHEROMONE; QUETIAPINE; SEROTONIN;

ADIPOGENESIS; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; ESCHERICHIA COLI; FEEDING; GENE MUTATION; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; NEMATODE LIFE CYCLE STAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DISEASE MODELS, ANIMAL; GENES, HELMINTH; LONGEVITY; MUTATION; OBESITY; RESEARCH; SIGNAL TRANSDUCTION;

CAENORHABDITIS; CAENORHABDITIS ELEGANS;

EID: 84857040428     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.93     Document Type: Review

References (65)

1. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. World Health Organization: Geneva, Switzerland, 1997.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
3. Bray GA. Obesity: A time bomb to be defused. Lancet 1998; 352: 160-161. (Pubitemid 28327794)
4. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97-106. (Pubitemid 128679649)
5. Hogan P, Dall T, Nikolov P, American Diabetes A. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917-932.
6. C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: A platform for investigating, 1998; 282: 2012-2018.
7. Baumeister R, Ge L. The worm in usFCaenorhabditis elegans as a model of human disease. Trends Biotechnol 2002; 20: 147-148. (Pubitemid 34242854)
8. Li H, Black PN, DiRusso CC. A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors. Anal Biochem 2005; 336: 11-19. (Pubitemid 39593494)
9. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 2003; 421: 268-272. (Pubitemid 36139130)
10. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 1998; 95: 8625-8629. (Pubitemid 28350538)
11. Yen K, Le TT, Bansal A, Narasimhan SD, Cheng JX, Tissenbaum HA. A comparative study of fat storage quantitation in nematode Caenorhabditis elegans using label and label-free methods. PLoS One 2010; 5: E12810.
12. Liu LX, Spoerke JM, Mulligan EL, Chen J, Reardon B, Westlund B et al. High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res 1999; 9: 859-867. (Pubitemid 29488445)
13. Brooks KK, Liang B,Watts JL. The influence of bacterial diet on fat storage in C. elegans. PLoS One 2009; 4: E7545.
14. Jeong PY, Kwon MS, Joo HJ, Paik YK. Molecular time-course and the metabolic basis of entry into dauer in Caenorhabditis elegans. PLoS One 2009; 4: E4162.
15. Atherton HJ, Jones OA, Malik S, Miska EA, Griffin JL. A comparative metabolomic study of NHR-49 in Caenorhabditis elegans and PPAR-Alpha in the mouse. FEBS Lett 2008; 582: 1661-1666.
16. Lakowski B, Hekimi S. The genetics of caloric restriction in Caenorhabditis elegans. Proc Natl Acad Sci USA 1998; 95: 13091-13096. (Pubitemid 28509529)
17. Sze JY, Victor M, Loer C, Shi Y, Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000; 403: 560-564. (Pubitemid 30082203)
18. Watts JL. Fat synthesis and adiposity regulation in Caenorhabditis elegans. Trends Endocrinol Metab 2009; 20: 58-65.
19. You YJ, Kim J, Raizen DM, Avery L. Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: A model for satiety. Cell Metab 2008; 7: 249-257. (Pubitemid 351285528)
20. Jones KT, Ashrafi K. Caenorhabditis elegans as an emerging model for studying the basic biology of obesity. Dis Model Mech 2009; 2: 224-229.
21. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997; 389: 994-999. (Pubitemid 27485694)
22. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997; 277: 942-946. (Pubitemid 27366677)
23. Das UN. GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 13-20. (Pubitemid 29182161)
24. Kramer JM, Davidge JT, Lockyer JM, Staveley BE. Expression of Drosophila FOXO regulates growth and can phenocopy starvation. BMC Dev Biol 2003; 3: 5.
25. Hertweck M, Gobel C, Baumeister R. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell 2004; 6: 577-588. (Pubitemid 38456185)
26. Tissenbaum HA, Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 1998; 148: 703-717. (Pubitemid 28087620)
27. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000; 407: 377-382.
28. Porte Jr. D, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: A critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 2005; 54: 1264-1276. (Pubitemid 40586653)
29. Laron Z. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens) 2008; 7: 24-27.
30. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993; 366: 461-464. (Pubitemid 24013878)
31. Kloting N, Bluher M. Extended longevity and insulin signaling in adipose tissue. Exp Gerontol 2005; 40: 878-883. (Pubitemid 41540437)
32. Lee SJ, Murphy CT, Kenyon C. Glucose shortens the life span of C. elegans by downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell Metab 2009; 10: 379-391.
33. Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA 2005; 102: 10993-10998. (Pubitemid 41105981)
34. Ceperuelo-Mallafre V, Miranda M, Chacon MR, Vilarrasa N, Megia A, Gutierrez C et al. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 3640-3645. (Pubitemid 47435350)
35. Prudente S, Flex E, Morini E, Turchi F, Capponi D, De Cosmo S et al. A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities. Diabetes 2007; 56: 1468-1474. (Pubitemid 46715624)
36. Garattini S, Bizzi A, Caccia S, Mennini T, Samanin R. Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol 1988; 11(Suppl 1): S8-S32.
37. Zarse K, Ristow M. Antidepressants of the serotonin-Antagonist type increase body fat and decrease lifespan of adult Caenorhabditis elegans. PLoS One 2008; 3: E4062.
38. Srinivasan S, Sadegh L, Elle IC, Christensen AG, Faergeman NJ, Ashrafi K. Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab 2008; 7: 533-544. (Pubitemid 351729208)
39. Laurence JZ, Moon RC. Four cases of 'retinitis pigmentosa' occurring in the same family, and accompanied by general imperfections of development. 1866. Obes Res 1995; 3: 400-403.
40. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003; 425: 628-633. (Pubitemid 37280147)
41. Pan J, Wang Q, Snell WJ. Cilium-generated signaling and ciliarelated disorders. Lab Invest 2005; 85: 452-463.
42. Fan Y, Esmail MA, Ansley SJ, Blacque OE, Boroevich K, Ross AJ et al. Mutations in a member of the Ras superfamily of small GTPbinding proteins causes Bardet-Biedl syndrome. Nat Genet 2004; 36: 989-993. (Pubitemid 39167496)
43. Mukhopadhyay A, Deplancke B, Walhout AJ, Tissenbaum HA. C. elegans tubby regulates life span and fat storage by two independent mechanisms. Cell Metab 2005; 2: 35-42. (Pubitemid 43239823)
44. Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G. Polygenic control of Caenorhabditis elegans fat storage. Nat Genet 2006; 38: 363-368.
45. Mukhopadhyay A, Pan X, Lambright DG, Tissenbaum HA. An endocytic pathway as a target of tubby for regulation of fat storage. EMBO Rep 2007; 8: 931-938. (Pubitemid 47500476)
46. Suh JM, Zeve D, McKay R, Seo J, Salo Z, Li R et al. Adipose is a conserved dosage-sensitive antiobesity gene. Cell Metab 2007; 6: 195-207. (Pubitemid 47324138)
47. Korotkova N, Chistoserdova L, Kuksa V, Lidstrom ME. Glyoxylate regeneration pathway in the methylotroph Methylobacterium extorquens AM1. J Bacteriol 2002; 184: 1750-1758. (Pubitemid 34188227)
48. Perez CL, Van Gilst MR. A 13C isotope labeling strategy reveals the influence of insulin signaling on lipogenesis in C. elegans. Cell Metab 2008; 8: 266-274.
49. Brey CW, Nelder MP, Hailemariam T, Gaugler R, Hashmi S. Kruppel-like family of transcription factors: An emerging new frontier in fat biology. Int J Biol Sci 2009; 5: 622-636.
50. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: The crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 2008; 19: 65-73. (Pubitemid 351317897)
51. Nomura T, Horikawa M, Shimamura S, Hashimoto T, Sakamoto K. Fat accumulation in Caenorhabditis elegans is mediated by SREBP homolog SBP-1. Genes Nutr 2010; 5: 17-27.
52. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002; 99: 11482-11486. (Pubitemid 34920951)
53. Ashrafi K. Obesity and the regulation of fat metabolism. WormBook 2007; 9: 1-20.
54. Van Gilst MR, Hadjivassiliou H, Jolly A, Yamamoto KR. Nuclear hormone receptor NHR-49 controls fat consumption and fatty acid composition in C. elegans. PLoS Biol 2005; 3: E53.
55. Golden A, Liu J, Cohen-Fix O. Inactivation of the C. elegans lipin homolog leads to ER disorganization and to defects in the breakdown and reassembly of the nuclear envelope. J Cell Sci 2009; 122: 1970-1978.
56. Elle IC, Olsen LC, Pultz D, Rodkaer SV, Faergeman NJ. Something worth dyeing for: Molecular tools for the dissection of lipid metabolism in Caenorhabditis elegans. FEBS Lett 2010; 584: 2183-2193.
57. Singh SP, Niemczyk M, Zimniak L, Zimniak P. Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE). Aging (Albany NY) 2009; 1: 68-80.
58. Meissner B, Boll M, Daniel H, Baumeister R. Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans. J Biol Chem 2004; 279: 36739-36745. (Pubitemid 39129021)
59. Spanier B, Lasch K, Marsch S, Benner J, Liao W, Hu H et al. How the intestinal peptide transporter PEPT-1 contributes to an obesity phenotype in Caenorhabditis elegans. PLoS One 2009; 4: E6279.
60. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: 1. Epidemiology. Thorax 2008; 63: 649-654.
61. Mohanna S, Baracco R, Seclen S. Lipid profile, waist circumference, and body mass index in a high altitude population. High Alt Med Biol 2006; 7: 245-255. (Pubitemid 46157311)
62. Taghibiglou C, Martin HG, Rose JK, Ivanova N, Lin CH, Lau HL et al. Essential role of SBP-1 activation in oxygen deprivation induced lipid accumulation and increase in body width/length ratio in Caenorhabditis elegans. FEBS Lett 2009; 583: 831-834.
63. Dwyer DS, Donohoe D, Lu XH, Aamodt EJ. Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs. Int Rev Neurobiol 2005; 65: 211-247. (Pubitemid 43588584)
64. Crossley NA, Constante M, McGuire P, Power P. Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: Meta-Analysis. Br J Psychiatry 2010; 196: 434-439.
65. Zheng J, Enright F, Keenan M, Finley J, Zhou J, Ye J et al. Resistant starch, fermented resistant starch, and short-chain fatty acids reduce intestinal fat deposition in Caenorhabditis elegans. J Agric Food Chem 2010; 58: 4744-4748.